AMWD vs TSLA

American Woodmark Corporation exhibits strong deterministic health per its Piotroski F-Score of 8/9, indicating robust operational efficiency and financial stability. However, this is severely undermined by a catastrophic earnings trajectory, with year-over-year EPS growth of -287.6% and a recent quarterly surprise of -5728.6%, signaling deep operational distress. The stock trades near its 52-week low at $39.50, despite a Graham Number of $40.20, suggesting minimal margin of safety. Its valuation metrics—P/E of 34.05 and Price/Sales of 0.38—are misleading given the negative operating margin and declining revenue. Analysts recommend 'buy' with a target of $59.00, but this is inconsistent with the deteriorating fundamentals and technical bearishness.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.